A detailed history of Ransom Advisory, LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Ransom Advisory, LTD holds 5,708 shares of ABT stock, worth $742,211. This represents 0.3% of its overall portfolio holdings.

Number of Shares
5,708
Previous 5,647 1.08%
Holding current value
$742,211
Previous $756 Million 99.9%
% of portfolio
0.3%
Previous 0.34%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 06, 2026

BUY
$123.62 - $134.59 $7,540 - $8,209
61 Added 1.08%
5,708 $742,000
Q3 2025

Oct 07, 2025

BUY
$120.51 - $136.62 $680,519 - $771,493
5,647 New
5,647 $756 Million
Q3 2025

Oct 03, 2025

SELL
$120.51 - $136.62 $704,380 - $798,543
-5,845 Closed
0 $756 Million
Q2 2025

Jul 08, 2025

BUY
$123.95 - $138.08 $123 - $138
1 Added 0.02%
5,845 $795 Million
Q1 2025

May 20, 2025

BUY
$111.1 - $140.22 $649,268 - $819,445
5,844 New
5,844 $775 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ransom Advisory, LTD Portfolio

Follow Ransom Advisory, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ransom Advisory, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ransom Advisory, LTD with notifications on news.